COVID-19 became the second leading cause of death globally in the year after it was declared a pandemic, according to a study published in the Lancet.
While heart disease remained the top killer, COVID “radically altered” the main five causes of death for the first time in 30 years, displacing stroke, the publication said. In 2021, 94 in every 100,000 people died from COVID, on an age-standardized basis.
Comments closedPM2.5 particles are tiny enough to enter the bloodstream and lodge in the lungs, where they contribute to respiratory problems such as asthma. They also can prompt heart attacks and strokes. And they have been linked to diabetes, obesity and dementia and may exacerbate COVID.
Comments closedFrom the earliest days of the COVID-19 pandemic, scientists have raised concerns about the potential for long-term health problems linked to SARS-CoV-2 and warned repeated infections are likely to increase the risk.
An association between COVID and cardiovascular disease emerged quickly.
And now — almost exactly four years since the first case was discovered in Wuhan — a growing body of scientific research is cautiously linking the inflammation caused by a COVID infection to diseases like Alzheimer’s and Parkinson’s as well as autoimmune conditions from bowel disease to rheumatoid arthritis.
Comments closedHigh levels of two blood biomarkers during infection could predict cognitive dysfunction, or “brain fog,” among COVID-19 survivors 6 and 12 months after hospitalization, according to a UK study published yesterday in Nature Medicine.
Comments closedMany people who have long COVID—a condition in which health issues persist months after infection—report struggling with “brain fog,” recurring memory and concentration lapses that make it difficult to function in everyday life. Now a new study has found these cognitive problems could result from blood clots triggered by infection, possibly through mechanisms like those that cause some types of dementia. These clots leave telltale protein signatures in blood, suggesting that testing for them could help predict, diagnose and possibly even treat long COVID.
Comments closedThe list of neurocognitive issues that Meropol’s team and other researchers must track is extensive: cognitive decline, changes in brain size and structure, depression and suicidal thinking, tremors, seizures, memory loss, and new or worsened dementia have all been linked to previous SARS-CoV-2 infections. In some cases, these longer-term problems occur even in patients with relatively mild COVID-19.
Comments closedResearchers at The University of Queensland have discovered that SARS-CoV-2 and other viruses can cause brain cells to fuse, initiating malfunctions that lead to chronic neurological symptoms.
Comments closedResearchers have demonstrated that a SARS-CoV-2 infection can induce brain cells to fuse together, with severe impacts on the functioning of neurons. Neurons may fuse together with other neurons or glia, and larger multicellular syncytia may be formed. The fusion of neurons may be one of the causes of the cognitive issues associated with COVID-19.
Comments closedIn a new study, researchers examined the cognitive impacts of COVID-19 on people with dementia. They found that having COVID-19 rapidly accelerated the structural and functional brain deterioration of patients with dementia, regardless of the type of dementia being experienced.
Comments closedA new study, published in the Journal of Alzheimer’s Disease Reports, has discovered that infection with SARS-CoV-2 (the virus that causes Covid) has a significant impact on cognitive function in patients with pre-existing dementia.
Comments closedDo not listen to powers that be who pretend that getting infected with COVID multiple times is now no big deal. They’re asking you to lower your guard for a nasty virus that can invade the brain, disregulate the immune system and damage the vascular system.
This strategy has led to predictable results — more direct deaths, more excess deaths, more disease and some 1.4 million Canadians reporting some form of long COVID over the last two years.
Comments closedCOVID-19 positive outpatients are at an increased risk of neurodegenerative disorders compared with individuals who tested negative for the virus, a new study presented today at the 8th European Academy of Neurology (EAN) Congress has shown.
The study, which analysed the health records of over half of the Danish population, found that those who had tested positive for COVID-19 were at an increased risk of Alzheimer’s disease, Parkinson’s disease, and ischaemic stroke.
Comments closed
